ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $ZION in the last 30 days.
See all $ZION insider activity →Zions Bancorporation (ZIONP) appointed Michael MacDonald as President of California Bank & Trust. He will also continue leading Zions Capital Markets and serve on the Executive Management Committee. The move is part of a mid-cycle leadership change to align with the bank's capital markets strategy.
Piper Sandler kept a Neutral rating on Zions Bancorp with a $69 price target, implying a 299.5% upside from the Oct 20 close. The bank's net interest income fell short of expectations due to a lower net interest margin, and loan growth expectations were revised downward, according to the analyst note.
TD Cowen maintained a Hold rating on Zions Bancorp with a $69 price target, implying a 298.8% upside from the Oct 19 close of $17.30. The bank's recent earnings missed expectations due to weaker net interest income and higher expenses, raising concerns about growth and execution risk. Loan growth guidance is modest, and the bank relies on net interest margin expansion for income.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning ZION (ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent ZION coverage spans earnings and financial news.
The appointment signals continuity in leadership, likely resulting in modest stock stability.
Analyst maintains neutral stance with a high price target, suggesting limited immediate upside pressure.
Analyst upgrade with a high price target may generate buying interest.
Analyst upgrade and earnings beat suggest upside for ZION.
Analyst reiteration may generate modest buying interest.
AlphAI scores every news story that mentions ZION with an AI model for sentiment and relevance, and aggregates insider trades from ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Zions Bancorporation (ZIONP) appointed Michael MacDonald as President of California Bank & Trust. He will also continue leading Zions Capital Markets and serve on the Executive Management Committee. The move is part of a mid-cycle leadership change to align with the bank's capital markets strategy.
1 min readPiper Sandler kept a Neutral rating on Zions Bancorp with a $69 price target, implying a 299.5% upside from the Oct 20 close. The bank's net interest income fell short of expectations due to a lower net interest margin, and loan growth expectations were revised downward, according to the analyst note.
1 min readTD Cowen maintained a Hold rating on Zions Bancorp with a $69 price target, implying a 298.8% upside from the Oct 19 close of $17.30. The bank's recent earnings missed expectations due to weaker net interest income and higher expenses, raising concerns about growth and execution risk. Loan growth guidance is modest, and the bank relies on net interest margin expansion for income.
1 min readDA Davidson raised its price target for Zions Bancorp (ZION) to $80 from $79, citing an earnings beat driven by provision benefits. The bank reported core EPS of $1.73, exceeding forecasts. ZION trades at a P/E of 8.05 and PEG of 0.17. Six analysts revised earnings upwards. The bank projects 8%-12% net interest income growth. Q3 2026 EPS was $1.78, beating estimates, but revenue missed forecasts. Jefferies lowered its target to $75.
2 min readRBC Capital maintained a Sector Perform rating on Zions Bancorp with a $76 price target, suggesting a 339.3% upside from the Oct 19 close of $17.30. The bank showed stable financial performance with strong deposit growth and a favorable outlook for loan growth and net interest income, according to the analyst note.
1 min readJefferies reduced Zions Bancorp's (ZION) price target to $75 from $80, citing a net interest income (NII) miss, though it maintained a Buy rating. ZION reported core EPS of $1.77, beating estimates, but core pre-provision net revenue missed expectations. The stock has a P/E ratio of 8.05 and a PEG ratio of 0.19, suggesting undervaluation. ZION guided for 8-12% NII growth over the next 12 months and a mid-3% net interest margin by 2027.
2 min readZions Bancorp (ZION) reported Q3 2026 earnings up 20%, driven by deposit growth. Net interest margin fell 4 basis points sequentially. Full-year 2026 operating leverage guidance was cut to 40-50 basis points. Loan growth outlook was reduced to 2-4% for Q3 2027, with caution on commercial real estate. Deposit costs are expected to rise to 2%. The company anticipates $17-20M revenue from the Basis acquisition in 2027. Share buybacks may increase, subject to regulatory approval.
3 min readNasdaq rose 1.11% while Dow slipped 0.07%, with S&P 500 up 0.66%. VIX fell 1.55 points. Lockheed Martin delivered a C-130J-30 to the U.S. Navy. F.N.B. reported Q3 net income of $152.9M. Haemonetics got FDA approval for PerQseal Elite. Zions Bancorporation Q3 earnings rose 20% YoY. Crown Holdings Q3 EPS up to $2.08.
3 min readZions Bancorporation reported a $3 million loan write-off, down from $56 million a year earlier. CEO Harris Simmons noted increased short- and medium-term interest rates, expecting stronger net interest income. The company completed the acquisition of Basis Multifamily Finance I, LLC, enhancing its commercial real estate services. Zions will discuss third-quarter financial results on October 19, 2026.
2 min readZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION) filed an SEC Form 8-K — Results of Operations and Financial Condition. Zions Bancorporation, N.A. One South Main Salt Lake City, UT 84133 October 19, 2026 www.zionsbancorporation.com Third Quarter 2026 Financial Results: FOR IMMEDIATE RELEASE Investor Contact: Jason Arbuckle (801) 844-7665 Media Contact: Jennifer Johnston (801) 844-7112 Zions Bancor
2 min read
